Comac Medical has conducted an assessment in IMP³rove – an instrument provided by the European Commission for measurement of the innovation potential of the company, which ranked the company among the growth champions in Europe.
IMP³rove assessment
October 19, 2015
Share:
News
Planning a clinical trial comes with numerous challenges, requiring a methodical approach for successful execution. However, unforeseen issues...
Abstract: In this prospective study, we assessed biomarkers of inflammation (IL-6 and SAA) from the serum of 120...
Landmark Changes Position Company for Continued Growth and Innovation Sofia, December 6, 2023 – Comac Medical, a leading...